A funding freeze by the Trump administration is reportedly impacting reproductive care and family planning funding, with tens of millions of dollars affected. The move may have broader implications for healthcare and biomedical research. The situation is part of a larger context of challenges to reproductive health care and rights, with potential consequences for access to care and research in the field.